Back to Search Start Over

2-Aminooxazole as a Novel Privileged Scaffold in Antitubercular Medicinal Chemistry.

Authors :
Azzali E
Girardini M
Annunziato G
Pavone M
Vacondio F
Mori G
Pasca MR
Costantino G
Pieroni M
Source :
ACS medicinal chemistry letters [ACS Med Chem Lett] 2020 Jun 08; Vol. 11 (7), pp. 1435-1441. Date of Electronic Publication: 2020 Jun 08 (Print Publication: 2020).
Publication Year :
2020

Abstract

To obtain effective eradication of numerous infectious diseases such as tuberculosis, it is important to supply the medicinal chemistry arsenal with novel chemical agents. Isosterism and bioisosterism are widely known concepts in the field of early drug discovery, and in several cases, rational isosteric replacements have contributed to improved efficacy and physicochemical characteristics throughout the hit-to-lead optimization process. However, sometimes the synthesis of isosteres might not be as straightforward as that of the parent compounds, and therefore, novel synthetic strategies must be elaborated. In this regard, we herein report the evaluation of a series of N-substituted 4-phenyl-2-aminooxazoles that, despite being isosteres of a widely used nucleus such as the 2-aminothiazole, have been only seldom explored. After elaboration of a convenient synthetic strategy, a small set of 2-aminothiazoles and their 2-aminooxazole counterparts were compared with regard to antitubercular activity and physicochemical characteristics.<br />Competing Interests: The authors declare no competing financial interest.<br /> (Copyright © 2020 American Chemical Society.)

Details

Language :
English
ISSN :
1948-5875
Volume :
11
Issue :
7
Database :
MEDLINE
Journal :
ACS medicinal chemistry letters
Publication Type :
Academic Journal
Accession number :
32676151
Full Text :
https://doi.org/10.1021/acsmedchemlett.0c00173